The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
Open accessAbstract
Summary Epidermal growth factor receptor (EGFR) is known to be critically involved in tissue development and homeostasis as well as in the pathogenesis of cancer. Here we showed that Foxp3+ regulatory T (Treg) cells express EGFR under inflammatory conditions. Stimulation with the EGF-like growth factor Amphiregulin (AREG) markedly enhanced Treg cell function in vitro, and in a colitis and tumor vaccination model we showed that AREG was critical for efficient Treg cell function in vivo. In addition, mast cell-derived AREG fully restored optimal Treg cell function. These findings reveal EGFR as a component in the regulation of local immune responses and establish a link between mast cells and Treg cells. Targeting of this immune regulatory mechanism may contribute to the therapeutic successes of EGFR-targeting treatments in cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“Starting with the direct killing of a portion of the tumor cells, the thereby released tumor antigens can prime antitumor immune responses de novo or reactivate dormant, anergic responses (Apetoh et al., 2007).”
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Khambata-Ford, S., Garrett, C. R., Meropol, N. J., Basik, M., Harbison, C. T., Wu, S., Wong, T. W., Huang, X., Takimoto, C. H., Godwin, A. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5437 · Cited by 1,125
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Mast cells are essential intermediaries in regulatory T-cell tolerance
Lu, L.-F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., et al. (2006) · Nature · doi:10.1038/nature05010 · Cited by 751
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Avraham, R., & Yarden, Y. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3048 · Cited by 672
Grimbaldeston, M. A., Chen, C.-C., Piliponsky, A. M., Tsai, M., Tam, S.-Y., & Galli, S. J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62055-x · Cited by 525
Montagut, C., Dalmases, A., Bellosillo, B., Crespo, M., Pairet, S., Iglesias, M., Salido, M., Gallen, M., Marsters, S., Tsai, S. P., et al. (2012) · Nature Medicine · doi:10.1038/nm.2609 · Cited by 513
Modeling T Cell Antigen Discrimination Based on Feedback Control of Digital ERK Responses
Altan-Bonnet, G., & Germain, R. N. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030356 · Cited by 468
Chen, F., Liu, Z., Wu, W., Rozo, C., Bowdridge, S., Millman, A., Van Rooijen, N., Urban, J. F., Wynn, T. A., & Gause, W. C. (2012) · Nature Medicine · doi:10.1038/nm.2628 · Cited by 449
Zhang, N., Schröppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, R., Ochando, J. C., Ding, Y., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.022 · Cited by 411
Jacobs, B., De Roock, W., Piessevaux, H., Van Oirbeek, R., Biesmans, B., De Schutter, J., Fieuws, S., Vandesompele, J., Peeters, M., Van Laethem, J.-L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3744 · Cited by 368
Huang, B., Lei, Z., Zhang, G.-M., Li, D., Song, C., Li, B., Liu, Y., Yuan, Y., Unkeless, J., Xiong, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-147033 · Cited by 345
Townsend, M. J., Fallon, P. G., Matthews, D. J., Smith, P., Jolin, H. E., & McKenzie, A. N. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00056-x · Cited by 328
Ferris, R. L., Jaffee, E. M., & Ferrone, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6360 · Cited by 320
The EGF receptor is required for efficient liver regeneration
Natarajan, A., Wagner, B., & Sibilia, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704126104 · Cited by 320
Self-citationTumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma
Ribatti, D., Ennas, M. G., Vacca, A., Ferreli, F., Nico, B., Orru, S., & Sirigu, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01152.x · Cited by 262
Johansson, A., Rudolfsson, S., Hammarsten, P., Halin, S., Pietras, K., Jones, J., Stattin, P., Egevad, L., Granfors, T., Wikström, P., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100070 · Cited by 216
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis
Burchill, M. A., Yang, J., Vang, K. B., & Farrar, M. A. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.005 · Cited by 199
Chan, G., Nogalski, M. T., & Yurochko, A. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908787106 · Cited by 199
Amphiregulin, a T H 2 Cytokine Enhancing Resistance to Nematodes
Zaiss, D. M., Yang, L., Shah, P. R., Kobie, J. J., Urban, J. F., & Mosmann, T. R. (2006) · Science · doi:10.1126/science.1133715 · Cited by 194
Self-citationIshikawa, N., Daigo, Y., Takano, A., Taniwaki, M., Kato, T., Hayama, S., Murakami, H., Takeshima, Y., Inai, K., Nishimura, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1556 · Cited by 194
Autoimmunity during lymphopenia: A two-hit model
Krupica, T., Fry, T. J., & Mackall, C. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.569 · Cited by 176
Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity
Guerau-de-Arellano, M., Martinic, M., Benoist, C., & Mathis, D. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090300 · Cited by 172
Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State
Schietinger, A., Delrow, J. J., Basom, R. S., Blattman, J. N., & Greenberg, P. D. (2012) · Science · doi:10.1126/science.1214277 · Cited by 169
Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis
Hershko, A. Y., Suzuki, R., Charles, N., Álvarez‐Errico, D., Sargent, J. L., Laurence, A. D. J., & Rivera, J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.013 · Cited by 141
Immune privilege induced by regulatory T cells in transplantation tolerance
Cobbold, S. P., Adams, E., Graça, L., Daley, S. R., Yates, S., Paterson, A. M., Robertson, N. J., Nolan, K. F., Fairchild, P. J., & Waldmann, H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00428.x · Cited by 135
Okumura, S., Sagara, H., Fukuda, T., Saito, H., & Okayama, Y. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.10.004 · Cited by 131
Mahtouk, K., Hose, D., Reme, T. X., Vos, J. D., Jourdan, M., Moreaux, J., Fiol, G., Raab, M. S., Jourdan, É., Grau, V., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208536 · Cited by 109
Campion, A. L., Gagnerault, M. C., Auffray, C., Bécourt, C., Poitrasson-Rivière, M., Lallemand, E., Bienvenu, B., Martin, B., Lepault, F., & Lucas, B. (2009) · Blood · doi:10.1182/blood-2008-12-192120 · Cited by 102
Tinhofer, I., Klinghammer, K. F., Weichert, W., Knödler, M., Stenzinger, A., Gauler, T. C., Budach, V., & Keilholz, U. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3338 · Cited by 93
Ju, M., Qiu, S., Gao, Q., Fan, J., Cai, M., Li, Y., & Tang, Z. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01182.x · Cited by 92
Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts
Wang, S., Oh, C. K., Cho, S., Hu, G., Martin, R. E., Demissie-Sanders, S., Li, K., Moyle, M., & Yao, Z. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.037 · Cited by 90
Comparative methodologies of regulatory T cell depletion in a murine melanoma model
Matsushita, N., Pilon‐Thomas, S., Martin, L. M., & Riker, A. I. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.012 · Cited by 89
Mast cells and eosinophils in invasive breast carcinoma
Amini, R., Aaltonen, K., Nevanlinna, H. A., Carvalho, R. F. D. S., Salonen, L., Heikkilä, P., & BLOMQVIST, C. P. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-165 · Cited by 86
EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate
Stern, K. A., Place, T. L., & Lill, N. L. (2008) · Biochemical Journal · doi:10.1042/bj20071505 · Cited by 78
Human basophils express amphiregulin in response to T cell–derived IL-3
Qi, Y., Operario, D. J., Oberholzer, C. M., Kobie, J. J., Looney, R. J., Georas, S. N., & Mosmann, T. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.040 · Cited by 45
Garrido, G., Lorenzano, P., Sánchez, B., Beausoleil, I., Alonso, D. F., Pérez, R., & Fernandez, L. E. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0313-4 · Cited by 44
Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells
Tsang, J. Y. S., Câmara, N. O. S., Eren, E., Schneider, H., Rudd, C. E., Lombardi, G., & Lechler, R. I. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605344 · Cited by 42
Amphiregulin Production by Human Eosinophils
Matsumoto, K., Fukuda, S., Nakamura, Y., & Saito, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000210652 · Cited by 35
Mekori, Y. A., & Hershko, A. Y. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00006 · Cited by 34
Cited by
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234
“Interestingly, it was recently reported that Areg might also impact Treg cells directly and enhance their ability to suppress immune responses (Zaiss et al., 2013).”
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Akbay, E. A., Koyama, S., Carretero, J., Altabef, A., Tchaicha, J. H., Christensen, C. L., Mikse, O. R., Cherniack, A. D., Beauchamp, E. M., Pugh, T. J., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0310 · Cited by 1,231
A Distinct Function of Regulatory T Cells in Tissue Protection
Arpaia, N., Green, J. A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., Treuting, P. M., & Rudensky, A. Y. (2015) · Cell · doi:10.1016/j.cell.2015.08.021 · Cited by 991
Promoting tissue regeneration by modulating the immune system
Julier, Z., Park, A. J., Briquez, P. S., & Martino, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.056 · Cited by 766
Biomaterials: Foreign Bodies or Tuners for the Immune Response?
Mariani, E., Lisignoli, G., Borzì, R. M., & Pulsatelli, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030636 · Cited by 706
Metadata
- Authors
- Zaiss, D. M. W., van Loosdregt, J., Gorlani, A., Bekker, C. P. J., Gröne, A., Sibilia, M., van Bergen en Henegouwen, P. M. P., Roovers, R. C., Coffer, P. J., & Sijts, A. J. A. M.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 38
- Issue
- 2
- Pages
- 275-284
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2008264147
- Cited by
- 418
- References
- 51
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.